These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 32340775)

  • 21. Strawberry extract presents antiplatelet activity by inhibition of inflammatory mediator of atherosclerosis (sP-selectin, sCD40L, RANTES, and IL-1β) and thrombus formation.
    Alarcón M; Fuentes E; Olate N; Navarrete S; Carrasco G; Palomo I
    Platelets; 2015; 26(3):224-9. PubMed ID: 24749953
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Platelet biology and functions: new concepts and clinical perspectives.
    van der Meijden PEJ; Heemskerk JWM
    Nat Rev Cardiol; 2019 Mar; 16(3):166-179. PubMed ID: 30429532
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-inflammatory effects of anti-platelet treatment in atherosclerosis.
    Arazi HC; Badimon JJ
    Curr Pharm Des; 2012; 18(28):4311-25. PubMed ID: 22236116
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Apolipoprotein B100 danger-associated signal 1 (ApoBDS-1) triggers platelet activation and boosts platelet-leukocyte proinflammatory responses.
    Assinger A; Wang Y; Butler LM; Hansson GK; Yan ZQ; Söderberg-Nauclér C; Ketelhuth DF
    Thromb Haemost; 2014 Aug; 112(2):332-41. PubMed ID: 24816772
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protease-Activated Receptor 1 Inhibitors: Novel Antiplatelet Drugs in Prevention of Atherothrombosis.
    Al-Khafaji K; Mutyala M; Al-Khafaji N; Harper Y; Ismail I; Hakim H; Arora RR
    Am J Ther; 2017; 24(6):e730-e736. PubMed ID: 26398717
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of the platelet in the pathogenesis of atherothrombosis.
    Steinhubl SR; Moliterno DJ
    Am J Cardiovasc Drugs; 2005; 5(6):399-408. PubMed ID: 16259528
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Platelet-mediated inflammation in cardiovascular disease. Potential role of platelet-endothelium interactions.
    Tsoumani ME; Kalantzi KI; Goudevenos IA; Tselepis AD
    Curr Vasc Pharmacol; 2012 Sep; 10(5):539-49. PubMed ID: 22338568
    [TBL] [Abstract][Full Text] [Related]  

  • 28. DL-3-n-butylphthalide inhibits platelet activation via inhibition of cPLA2-mediated TXA2 synthesis and phosphodiesterase.
    Ye J; Zhai L; Zhang S; Zhang Y; Chen L; Hu L; Zhang S; Ding Z
    Platelets; 2015; 26(8):736-44. PubMed ID: 25734213
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Platelets: pleiotropic roles in atherogenesis and atherothrombosis.
    Linden MD; Jackson DE
    Int J Biochem Cell Biol; 2010 Nov; 42(11):1762-6. PubMed ID: 20673808
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combined antiplatelet therapy: still a sweeping combination in cardiology.
    Manolis AS; Manolis TA; Papadimitriou P; Koulouris S; Melita H
    Cardiovasc Hematol Agents Med Chem; 2013 Jun; 11(2):136-67. PubMed ID: 23597106
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of antiplatelet therapy on inflammatory markers in atherothrombotic patients.
    Muhlestein JB
    Thromb Haemost; 2010 Jan; 103(1):71-82. PubMed ID: 20062914
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vitamin D levels and high-residual platelet reactivity in patients receiving dual antiplatelet therapy with clopidogrel or ticagrelor.
    Verdoia M; Pergolini P; Rolla R; Sartori C; Nardin M; Schaffer A; Barbieri L; Daffara V; Marino P; Bellomo G; Suryapranata H; De Luca G;
    Platelets; 2016 Sep; 27(6):576-82. PubMed ID: 27540959
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Platelet activation in atherogenesis associated with low-grade inflammation.
    Antoniades C; Bakogiannis C; Tousoulis D; Demosthenous M; Marinou K; Stefanadis C
    Inflamm Allergy Drug Targets; 2010 Dec; 9(5):334-45. PubMed ID: 20632958
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Platelet-activating factor (PAF-acether) secretion from platelets: effect of aggregating agents.
    Chignard M; Le Couedic JP; Vargaftig BB; Benveniste J
    Br J Haematol; 1980 Nov; 46(3):455-64. PubMed ID: 6778498
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Platelet activating factor: A potential biomarker in acute coronary syndrome?
    Palur Ramakrishnan AV; Varghese TP; Vanapalli S; Nair NK; Mingate MD
    Cardiovasc Ther; 2017 Feb; 35(1):64-70. PubMed ID: 27790832
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of a unique dihydropyrimidinone, ethyl 4-(4'-heptanoyloxyphenyl)-6-methyl-3,4-dihydropyrimidin-2-one-5-carboxylate, as an effective antithrombotic agent in a rat experimental model.
    Priya N; Singh P; Bhatia S; Medhi B; Prasad AK; Parmar VS; Raj HG
    J Pharm Pharmacol; 2011 Sep; 63(9):1175-85. PubMed ID: 21827490
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Significance of urinary 11-dehydro-thromboxane B
    Simeone P; Boccatonda A; Liani R; Santilli F
    Ageing Res Rev; 2018 Dec; 48():51-78. PubMed ID: 30273676
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Amifostine, a reactive oxigen species scavenger with radiation- and chemo-protective properties, inhibits in vitro platelet activation induced by ADP, collagen or PAF.
    Porta C; Maiolo A; Tua A; Grignani G
    Haematologica; 2000 Aug; 85(8):820-5. PubMed ID: 10942928
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antiplatelet activity of L-sulforaphane by regulation of platelet activation factors, glycoprotein IIb/IIIa and thromboxane A2.
    Oh CH; Shin JI; Mo SJ; Yun SJ; Kim SH; Rhee YH
    Blood Coagul Fibrinolysis; 2013 Jul; 24(5):498-504. PubMed ID: 23412354
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of preparative procedures on assay of platelet function and apparent effects of antiplatelet agents.
    Madsen NJ; Holmes CE; Serrano FA; Sobel BE; Schneider DJ
    Am J Cardiol; 2007 Aug; 100(4):722-7. PubMed ID: 17697836
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.